Kim Kelderman
2022
In 2022, Kim Kelderman earned a total compensation of $2.9M as President, Diagnostics and Genomics at Bio-Techne, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $776,445 |
|---|---|
| Option Awards | $1,199,909 |
| Salary | $561,800 |
| Stock Awards | $399,911 |
| Other | $9,302 |
| Total | $2,947,367 |
Kelderman received $1.2M in option awards, accounting for 41% of the total pay in 2022.
Kelderman also received $776.4K in non-equity incentive plan, $561.8K in salary, $399.9K in stock awards and $9.3K in other compensation.
Rankings
In 2022, Kim Kelderman's compensation ranked 1,200th out of 5,387 executives tracked by ExecPay. In other words, Kelderman earned more than 77.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,200 out of 5,387 | 78th |
Division Manufacturing | 580 out of 2,922 | 80th |
Major group Chemicals And Allied Products | 208 out of 1,304 | 84th |
Industry group Drugs | 187 out of 1,209 | 85th |
Industry Biological Products, Except Diagnostic Substances | 42 out of 280 | 85th |
Source: SEC filing on September 14, 2022.
Kelderman's colleagues
We found five more compensation records of executives who worked with Kim Kelderman at Bio-Techne in 2022.